Promoter methylation of the RGC32 gene in nonsmall cell lung cancer

Cancer

Volumn 117, Issue 3, 2011, Pages 590-596

  Kim, Dong Sun ^a   Lee, Ji Yun ^a   Lee, Su Man ^a   Choi, Jin Eun ^a   Cho, Sukki ^a   Park, Jae Yong ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

hypermethylation; MSP; NSCLC; overall survival; RGC32

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; CELL CYCLE REGULATION; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RESPONSE GENE TO COMPLEMENT 32; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 79251497024     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25451     Document Type: Article

References (16)

1. Baylin SB, Herman JG., DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000; 16: 168-174.
2. Jones PA, Baylin SB., The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3: 415-428.
3. Belinsky SA., Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer. 2004; 4: 1-11.
4. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA., DNA hypermethylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene. 2002; 21: 5450-5461.
5. Kim DS, Cha SI, Lee JH, et al. Aberrant DNA methylation profiles of nonsmall cell lung cancers in a Korean population. Lung Cancer. 2007; 58: 1-6.
6. Alberg AJ, Brock MV, Samet JM., Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005; 23: 3175-3185.
7. Sherr CJ., Cancer cell cycles. Science. 1996; 274: 1672-1677.
8. Badea TC, Niculescu FI, Soane L, Shin ML, Rus H., Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J Biol Chem. 1998; 273: 26977-26981.
9. Badea T, Niculescu F, Soane L, et al. RGC-32 increase p34CDC2 kinase activity and entry of aortic smooth cells into S-phase. J Biol Chem. 2002; 277: 502-508.
10. Vlaicu SI, Cudrici C, Ito T, et al. Role of response gene to complement 32 in disease. Arch Immunol Ther Exp. 2008; 56: 115-122.
11. Fosbrink M, Cudrici C, Niculescu F, et al. Overexpression of RGC-32 in colon and other tumors. Exp Mol Pathol. 2005; 78: 116-122.
12. Saigusa K, Imoto I, Tanikawa C, et al. RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest. Oncogene. 2007; 26: 1110-1121.
13. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60: 5954-5958.
14. Takai N, Kawamata N, Walsh CS, et al. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol Cancer Res. 2005; 3: 261-269.
15. Belinsky SA, Palmisano WA, Gilliland ED, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002; 62: 2370-2377.
16. Guo M, House MG, Hooker C, et al. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res. 2004; 10: 5131-5136.